What is the potential role of polyunsaturated fatty acids in controlling dyslipidemia in patients with polycystic ovary syndrome?

Reference

• Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am. J.Med.111, 607–613 (2001).
   Google Scholar
• Doi SA, Abbas JM, Parkinson L, Chakraborty J, Akanji AO. LDL species heterogeneity in the atherogenic dyslipidemia of polycystic ovary syndrome. Am.J.Clin.Pathol.129, 802–810 (2008).
   Google Scholar
• Moon JY, Kwon HM, Kwon SW etal. Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease. Cardiology108, 282–289 (2007).
   Google Scholar
• Berneis K, Rizzo M, Hersberger M etal. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Int.J.Clin. Pract. 63, 56–62 (2009).
   Google Scholar
• Deckelbaum RJ, Worgall TS, Seo T. n-3 fatty acids and gene expression. Am.J.Clin.Nutr. 83, S1520–S1525 (2006).
   Google Scholar
• Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J.Clin.Nutr.83, S1467–S1476 (2006).
   Google Scholar
• Tierney AC, McMonagle J, Shaw DI etal. Effects of dietary fat modification on insulin sensitivity and other risk factors of the metabolic syndrome – LIPGENE: a European randomized dietary intervention study. Int.J.Obes.(Lond.) 35(6), 800–809 (2010).
   Google Scholar
• Jiménez-Gómez Y, Marín C, Peérez-Martínez P etal. A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome. J.Nutr.140, 1595–1601 (2010).
   Google Scholar
• Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am.J.Clin. Nutr.65, S1645–S1654 (1997).
   Google Scholar
• Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects.Am. J.Clin.Nutr.70, 817–825 (1999).
   Google Scholar
• Mori TA, Burke V, Puddey IB etal. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J.Clin.Nutr. 71, 1085–1094 (2000).
   Google Scholar
• Griffin MD, Sanders TA, Davies IG etal. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 years: the OPTILIP study. Am.J.Clin. Nutr. 84, 1290–1298 (2006).
   Google Scholar
• Neff LM, Culiner J, Cunningham-Rundles S etal. Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. J.Nutr. 141, 207–213 (2011).
   Google Scholar
• Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. Am.J.Cardiol. 102, 429–433 (2008).
   Google Scholar
• Lu G, Windsor SL, Harris WS. Omega-3 fatty acids alter lipoprotein subfraction distributions and the invitro conversion of very low density lipoproteins to low density lipoproteins. J.Nutr.Biochem. 10, 151–158 (1999).
   Google Scholar
• Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52, 908–915 (2003).
   Google Scholar
• Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R. Role of diet in the treatment of polycystic ovary syndrome. Fertil. Steril. 85, 679–688 (2006).
   Google Scholar
• Kasim-Karakas SE, Almario RU, Gregory L, Wong R, Todd H, Lasley BL. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. J.Clin.Endocrinol.Metab. 89, 615–620 (2004).
   Google Scholar
• Kalgaonkar S, Almario RU, Gurusinghe D etal. Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS. Eur.J.Clin.Nutr.65, 386–393 (2011).
   Google Scholar
• Cussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J.Clin. Endocrinol.Metab. 94, 3842–3848 (2009).
   Google Scholar
• Phelan N, O’Connor A, Kyaw Tun T etal. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional ana lysis and a randomized, placebo-controlled, crossover trial. Am.J.Clin. Nutr. 93, 652–662 (2011).
   Google Scholar
• Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J.Clin.Endocrinol. Metab. 92, 3490–3497 (2007).
   Google Scholar
• Westerbacka J, Corner A, Tiikkainen M etal. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47, 1360–1369 (2004).
   Google Scholar
• Messier V, Karelis AD, Robillard ME etal. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 59, 20–24 (2010).
   Google Scholar
• Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis197, 12–24 (2008).
   Google Scholar
• Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides?Curr.Opin.Lipidol.17, 387–393 (2006).
   Google Scholar
• Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.ExpertRev. Cardiovasc.Ther. 6, 391–409 (2008).
   Google Scholar
• Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J.LipidRes. 44, 455–463 (2003).
   Google Scholar
• Djousse L, Gaziano JM, Buring JE, Lee IM. Dietary omega-3 fatty acids and fish consumption and risk of Type 2 diabetes. Am. J.Clin.Nutr.93, 143–150 (2011).
   Google Scholar